Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.
Derrick J
DJ
Stobaugh
Parakkal
P
Deepak
Eli D
ED
Ehrenpreis
D000152:Acne Vulgaris / Q000188:drug therapy*; D016907:Adverse Drug Reaction Reporting Systems; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000139:chemically induced / Q000517:prevention & control*; D015474:Isotretinoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration
D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D015474:Isotretinoin